Adaptation of Chinese and English versions of the Psoriatic Arthritis Quality of Life (PsAQoL) scale for use in Singapore

被引:8
作者
Leung, Ying Ying [1 ,2 ]
Thumboo, Julian [1 ,2 ]
Rouse, Matthew [3 ]
McKenna, Stephen P. [4 ]
机构
[1] Singapore Gen Hosp, Dept Rheumatol & Immunol, Level 4,20 Coll Rd, Singapore S169856, Singapore
[2] Duke NUS Med Sch, Singapore, Singapore
[3] Galen Res Ltd, Manchester, Lancs, England
[4] Univ Manchester, Sch Hlth Sci, Manchester, Lancs, England
来源
BMC MUSCULOSKELETAL DISORDERS | 2016年 / 17卷
关键词
Psoriatic arthritis; Quality of life; outcome measures; cross cultural adaptation; HEALTH-ASSESSMENT QUESTIONNAIRE; COMPOSITE DISEASE-ACTIVITY; RHEUMATOID-ARTHRITIS; INSTRUMENT; SF-36; ASSUMPTIONS; VALIDATION; VALIDITY; CRITERIA; OUTCOMES;
D O I
10.1186/s12891-016-1292-4
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: To develop Singapore Chinese and English versions of the Psoriatic Arthritis Quality of Life (PsAQoL) scale that were equivalent to and met the same psychometric and acceptability standards as the original UK measure. Methods: Translation of the original PsAQoL into contextualised English and Chinese versions for use in Singapore was performed by professional and lay translation panels. Ten Chinese speaking and ten English speaking local patients were interviewed to assess face and content validity. Psoriatic arthritis (PsA) patients (either Chinese or English speaking) fulfilling the Classification criteria of Psoriatic Arthritis were then invited to participate in a validation survey. Clinical variables, the Health Assessment Questionnaire (HAQ) and the Medical Outcome Short-form 36 (SF-36) were used as comparator instruments for convergent validity. A separate sample of PsA patients were invited to participate in a test-retest postal study, with two weeks between administrations. Results: The validation sample included 98 patients (51 % men) with a mean (SD) age of 51.5 (13.8) years. The PsAQoL had excellent internal consistency (Cronbach's a = 0.92) and scores on the measure were moderately correlated with health status measures (pain, HAQ score, SF-36 scores) and patient and physician global assessments. The scale was able to distinguish between groups with active or inactive disease assessed by composite scores, HAQ and minimal disease activity. Test-retest reliability was excellent (r = 0.92). Conclusions: This study provides evidence that the adapted English and Chinese versions of the PsAQoL can be used in clinical studies with PsA patients in Singapore.
引用
收藏
页数:7
相关论文
共 37 条
[1]   Adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) instrument for Sweden [J].
Billing, E. ;
McKenna, S. P. ;
Staun, M. ;
Lindqvist, U. .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2010, 39 (03) :223-228
[2]   Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment [J].
Coates, L. C. ;
Fransen, J. ;
Helliwell, P. S. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) :48-53
[3]   The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis [J].
Coates, Laura C. ;
Navarro-Coy, Nuria ;
Brown, Sarah R. ;
Brown, Sarah ;
McParland, Lucy ;
Collier, Howard ;
Skinner, Emma ;
Law, Jennifer ;
Moverley, Anna ;
Pavitt, Sue ;
Hulme, Claire ;
Emery, Paul ;
Conaghan, Philip G. ;
Helliwell, Philip S. .
BMC MUSCULOSKELETAL DISORDERS, 2013, 14
[4]  
DeFrancis J., 1984, CHINESE LANGUAGE FAC
[5]  
Department of Statistics MoTaI Republic of Singapore, 2010, CENS POP 2010
[6]   The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus [J].
Doward, L. C. ;
McKenna, S. P. ;
Whalley, D. ;
Tennant, A. ;
Griffiths, B. ;
Emery, P. ;
Veale, D. J. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (02) :196-200
[7]   Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis [J].
Doward, LC ;
Spoorenberg, A ;
Cook, SA ;
Whalley, D ;
Helliwell, PS ;
Kay, LJ ;
McKenna, SP ;
Tennant, A ;
van der Heijde, D ;
Chamberlain, MA .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (01) :20-26
[8]   Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set [J].
FitzGerald, Oliver ;
Helliwell, Philip ;
Mease, Philip ;
Mumtaz, Aizad ;
Coates, Laura ;
Pedersen, Ronald ;
Nab, Henk ;
Molta, Charles .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (03) :358-362
[9]   MEASUREMENT OF PATIENT OUTCOME IN ARTHRITIS [J].
FRIES, JF ;
SPITZ, P ;
KRAINES, RG ;
HOLMAN, HR .
ARTHRITIS AND RHEUMATISM, 1980, 23 (02) :137-145
[10]   Effect of Certolizumab Pegol on Multiple Facets of Psoriatic Arthritis as Reported by Patients: 24-Week Patient-Reported Outcome Results of a Phase III, Multicenter Study [J].
Gladman, D. ;
Fleischmann, R. ;
Coteur, G. ;
Woltering, F. ;
Mease, P. J. .
ARTHRITIS CARE & RESEARCH, 2014, 66 (07) :1085-1092